Sneed Jr. v. AcelRx Pharmaceuticals, Inc.

Good Law
United States District Court, Northern District of CaliforniaDecember 16, 20215:21-cv-04353California2,992 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 AARON SNEED JR., Case No. 21-cv-04353-BLF

Plaintiff,

ORDER APPOINTING AARON SNEED

v. AND YAACOV MUSRY AS LEAD

PLAINTIFFS AND POMERANTZ LLP

ACELRX PHARMACEUTICALS, INC., et AS LEAD COUNSEL al., [Re: ECF Nos. 28, 33] Defendants. 12 Before the Court are two1 competing motions to appoint lead plaintiffs and lead counsel in this securities class action brought against AcelRx Pharmaceuticals, Inc., Vincent Angotti, and Raffi Asadorian over allegedly misleading statements made about AcelRx’s DSUIVA drug. The first motion is brought by putative lead plaintiffs Aaron Sneed and Yaacov Musry and their putative counsel Pomerantz LLP. ECF No. 28 (“S&M Motion”). The second is brought by putative lead plaintiff Paul Dupré and his putative counsel Roche Freedman LLP. ECF No. 33 (“Dupré Motion”). Each party has filed an opposition to the competing motion. ECF Nos. 36, 38. 20…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.